ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,806, issued on July 8, was assigned to GLYCOM A/S (Horsholm, Denmark).

"HMO production" was invented by Manos Papadakis (Bronshoj, Denmark) and Katrine Bych Kampmann (Valby, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic acid encoding a protein of the MFS superfamily; and methods using said cell for the production the oligosaccharide, preferably an HMO."

The patent was filed on Jan. 22, 2021, under Application No. 17/759,261.

*For further information, including images, ch...